PRE-CLINICAL DEVELOPMENT COLLABORATION AGREEMENTPre-Clinical Development Collaboration Agreement • February 26th, 2009 • Isis Pharmaceuticals Inc • Pharmaceutical preparations • England
Contract Type FiledFebruary 26th, 2009 Company Industry JurisdictionThis Pre-Clinical Development Collaboration Agreement (this “Agreement”) is entered into effective as of March 23, 2007 (the “Effective Date”) by and between Isis Pharmaceuticals, Inc., a Delaware corporation (“Isis”) and Korea Institute of Toxicology, a Korean government-established institute for non-clinical research (“KIT”).